Results for the First Quarter 2020

Sales for the quarter ended at a record high MNOK 103.1 (MNOK 88.7), a 16.2% increase.
This was driven by strong growth in capital sales of systems in Japan after regulatory approval of MiraQ™.

Read the full report and presentation below.

1.quarter 2020 report

Medistim Q1 2020 presentation